Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
167.00    2.00 (1.21%)
Bid:
165.50
Ask:
168.50
Spread: 3.00 (1.813%)
Market Cap: £32.61m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Director/PDMR Shareholding

19 Jan 2018 07:00

RNS Number : 3284C
Palace Capital PLC
19 January 2018
 

Palace Capital plc

 

("Palace Capital" or the "Company")

 

Director/PDMR shareholding

 

The Board of Palace Capital has been notified that Stanley Davis, Non-Executive Chairman of the Company, on 18 January 2018, purchased 100,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 330 pence per Ordinary Share. As a result of this purchase, Mr Davis interest in the Company is 1,665,287 Ordinary Shares, which represents approximately 3.63 per cent. of the voting rights over the Company's share capital.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Stanley Harold Davis

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Palace Capital plc

b)

LEI

2138009JDFQOXJFCJQ05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Palace Capital plc

 

Identification code (ISIN) for Palace Capital plc ordinary shares: GB00BF5SGF06

 

b)

Nature of the transaction

Purchase of shares

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

330p

100,000

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

18 January 2018

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

Date: 19 January 2018

 

For further information, contact:

 

Palace Capital plc

Neil Sinclair, Chief Executive

Stephen Silvester, Finance Director

Tel. +44 (0)20 3301 8331

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Nick Naylor / James Reeve / Asha Chotai

Tel. +44 (0)20 3328 5656

 

Arden Partners plc (Joint Broker)

Chris Hardie / Ciaran Walsh

Tel. +44 (0)207 614 5917

 

Capital Access Group (Financial PR)

Scott Fulton

Tel. +44 (0)20 3763 3400

 

About Palace Capital plc (www.palacecapitalplc.com):

 

Palace Capital is a UK property investment company admitted to trading on AIM, a market operated by the London Stock Exchange (LSE: PCA). The Company is not sector specific and looks for opportunities where it can enhance the long-term income and capital value through asset management and strategic capital development in locations outside London. In its last reported financial year, Palace Capital produced a 20.0% increase in adjusted profit before tax, a 7.0% uplift in EPRA NAV per share and a 16.0% increase in dividends.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLFFVILAITLIT
Date   Source Headline
27th May 20264:57 pmRNSHolding(s) in Company
1st May 20261:45 pmRNSTotal Voting Rights
24th Apr 20269:15 amRNSHolding(s) in Company
24th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20267:00 amRNSFurther Share Buyback Programme
21st Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20263:03 pmRNSHolding(s) in Company
17th Apr 20267:00 amRNSShare Buyback Programme
16th Apr 20267:00 amRNSPORTFOLIO VALUATION AS AT 31 MARCH 2026
2nd Apr 20267:00 amRNSHolding(s) in Company
19th Mar 20267:00 amRNSDividend Declaration
4th Mar 20263:02 pmRNSHolding(s) in Company
9th Feb 20267:00 amRNSDisposal Update
23rd Jan 20264:30 pmRNSWithdrawal of Meeting Notice and Board Changes
8th Jan 20267:00 amRNSRESPONSE TO LAKESTREET CAPITAL’S ANNOUNCEMENT
5th Jan 202612:15 pmRNSResponse to Lakestreet Capital Partners AG
5th Jan 20267:00 amRNSLAKESTREET DEMANDS CHANGE AT PALACE CAPITAL
4th Dec 20259:01 amRNSHolding(s) in Company
4th Dec 20259:00 amRNSHolding(s) in Company
1st Dec 202512:47 pmRNSHolding(s) in Company
1st Dec 202512:45 pmRNSHolding(s) in Company
27th Nov 20251:32 pmRNSDividend Declaration
27th Nov 20257:00 amRNSInterim Results
5th Nov 202511:18 amRNSHolding(s) in Company
5th Nov 202511:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSHolding(s) in Company
25th Sep 20257:00 amRNSChange of Broker
18th Sep 20257:00 amRNSDividend Declaration
12th Sep 202512:02 pmRNSHolding(s) in Company
10th Sep 202512:07 pmRNSHolding(s) in Company
4th Sep 20251:59 pmRNSHolding(s) in Company
3rd Sep 202511:19 amRNSHolding(s) in Company
3rd Sep 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSResult of Tender Offer
26th Aug 202512:32 pmRNSResult of General Meeting
31st Jul 20257:00 amRNSProposed Tender Offer & Notice of General Meeting
9th Jul 202511:00 amRNSResult of AGM
6th Jun 202511:00 amRNSAnnual Report and Notice of Annual General Meeting
5th Jun 20257:00 amRNSPreliminary Results for year ended 31 March 2025
30th Apr 20257:00 amRNSTRADING AND STRATEGY UPDATE
17th Apr 20257:00 amRNSHolding(s) in Company
11th Apr 20251:30 pmRNSDISPOSALS, DEBT AND CASH UPDATE
11th Mar 20257:00 amRNSDividend Declaration
10th Dec 20241:12 pmRNSHolding(s) in Company
15th Nov 202412:59 pmRNSHolding(s) in Company
14th Nov 20247:00 amRNSInterim Results
12th Nov 202412:00 pmRNSNotice of Results
9th Oct 202412:16 pmRNSHolding(s) in Company
24th Sep 202412:00 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.